tag:blogger.com,1999:blog-5088549013288027552Thu, 16 Feb 2012 07:40:08 +0000TorontoRNA messenger from M.ulcerans and M.marinum In silico analisysThe Isolation and Characterization of Novel MycobacteriophagesEndotoxin removalphiMmar09 and phiMmar10Acinetobacter baumannii genomes and Nucleotide sequence statisticsReceptor?GC SkewPHAGESPOIRS and P.H.A.G.EFood and BacteriophagesFasta codesTo read up again and againLytic Efficiency of MycobacteriophagesWorking with Pseudomonas Phages by in Silico analysisBacteriophage Life CycleD29 phage integrasePhage Therapy CenterSampling techniques for laboratory diagnosis of Buruli ulcerMycobacterial Cell WallVideoA Database about Mycobacterium ulceransFifth: phiMmar05genus ProteusMycobacterium phages for Mycobacterium ulceransPhage Therapy diagrambiotechnology and medicine.Mycobacterium ulcerans Agy99Disassembly of Thermotoga maritima thyX proteinBxz2DNA Dot plot of Acinetobacter baumannii genomesMycobacterial Hostsall phiMu and D29 mycobacterium phage3°- Is Cystic fibrosis disease a potential target for Biocontrol?2012:Exploiting bacteriophages for bioscienceEvidence Phage TherapySixth: phiMmar06Microgen companyBiofilmInnovative Drug Discovery Workshopstarting project on phage therapy My.ulceranscomplete genomeMark H.Adams's Book: BacteriophagesFourth: phiMmar04Staphylococcus aureusFrom Hubert MazureSalmonella: The New SuperbugAntibioticsBiocontrol of Enteric septicaemia of Catfishvibrio vulnificusHow to identify Nucleic Acid binding Motifs in Protein SequencesFrom: PHERECYDES PharmaBacteriophage Plaque MorphologyPhage case historyMy Diagnosis from Phage InternationalViridaxThe Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure?First: phiMmar01ASM 2011 Annual Scientific Meeting: Microbiology on the EdgeBacterial StocksQuorum SensingwoundsMycoBrowserGoing in search of phages for Mycobacterium ulceransPartial ConclusionsCpG plot by EmbossEndotoxinsL5 mycobacteriophage and L5p 71 repressorTargeted Genetics Corporation Proposes Combination With Biocontrol LimitedChaos game by EmbossPhage Therapy in Belgium4°- Is Cystic fibrosis disease a potential target for Biocontrol?Acinetobacter baumannii (MDR)M.ulcerans Agy99 polypeptidesPhage Therapy News from RussiaGenome identity of mycobacteriophagesBuruli and the best stage for the therapy1.PCR Method for Genotype Analysis of Mycobacterium ulceransSepsisPseudomonas aeruginosaM.Marinum and M.smegmatisPalindromesphiMmar07Phage therapy conditionsSecond: phiMmar02Buruli ulcer diseaseMycobacterium ulcerans Agy99 from Integrated Microbial GenomeMycobacterium smegmatis: Mpr protein2°- Is Cystic fibrosis disease a potential target for Biocontrol?Examining GenomesStep by step: Comparisons among D29 phageIndian TB cases 'can't be cured' ( But DS6A phage could be used)Receptors..?phiMmar08Phages 2011Escherichia coliVirulence factors of Mycobacterium ulceransPhage treatment of human infectionsCommercial phage preparationsMutation rateISTCPoint of viewAcinetobacter baumannii:In silico 2D-SDS-PAGEMay an Outbreak of Cholera be stopped down by Bacteriophages?5°- Is Cystic fibrosis disease a potential target for Biocontrol?M.ulcerans and M.smegmatis:In silico 2D-SDS-PAGEBioinformatics2.PCR Method for Genotype Analysis of Mycobacterium ulceransNucleotide sequence statistics for genomesAll phiMmarM.smegmatis Mpr protein alignment with M.ulcerans and M.marinum proteinsIs Phage Therapy possible in Buruli ulcer disease?By Unipro UGENE: Integrated Bioinformatics ToolsHerxheimer reactionMycobacterium phagesMorphology of Mature Mycobacterium ulcerans ColoniesMycobacterium ulcerans strain Agy99 and its 174-kb pMUM001 plasmidDNA Dot PlotCDS from phagesExploring Mycobacterium ulcerans1°- Is Cystic fibrosis disease a potential target for Biocontrol?Phage Therapycodons of mycobacteriophagesRestriction analysis6°-chronic lung infection with Pseudomonas in cystic fibrosis animal modelsMy remarks about Mycobacterium ulcerans genomegenus KlebsiellaPhage therapy: myth or reality?Phage immunologyCell wall of bacteriaISTC DatabasesCommentAlignment with genes or proteins from mycobacterium phagesD29CanadaAcinetobacter baumannii genomesOpen Reading FrameBiofilms and Infectious DiseasesAre there now utilizable Mycobacteriophages for Phage Therapy in Buruli ?Which is the Phage receptor? Third part.NewsPhage Therapy in FranceSimulation of Restriction AnalysisWhich is the Phage receptor? Fourth part.Clinical Trials for phage therapyM.marinumPhenotypical DelayPhage Therapy critical pointsPhage Therapy and the Fatal BlowCronobacter spp.Limulus amebocyte lysateD29 mycobacterium phage gp48 protein modelHow to recognize a bacterial promotersGenome IdentityTrialsHow to find Walker A motif and Walker B motif in the proteinsNestlé Nutrition CorporateThe Temporariness's PrincipleStreptococcus InfectionsCancer and BacteriophagesPhage CocktailNew Delhi metallo-β-lactamase 1 (NDM-1)gp48 D29 mycobacterium phage protein modelAntimicrobial Research ( SAR-2011)Genome comparison between D29 and L5 mycobacteriophagesThird: phiMmar032011Genome Skew for M.ulceransORFs of MycobacteriophagesM.ulceransD29 and L5 mycobacteriophages:In silico 2D-SDS-PAGEHow to study the structure of lysin B from Mycobacteriophage D29Phage-Antibiotic SynergyL5 phage integrase and Prophage integrase of M.ulcerans comparisonFrom the only information for growing Phages on Mycobacterium ulceransFrequency rate between Lytic phages and Lysogenic phagesThe ESKAPE PathogensMarketing point of view on Phage therapyPhage titerthe best view of M.ulcerans genome comparisonL5 and TM4 phages what have in common?Essential RequirementsMycobacterium marinum and Mycobacterium ulcerans:pater et filius28th European society for Paediatric infectious diseasesgenus EnterococcusHow to study any Bacteriophage proteinM.smegmatis and D29 mycobacteriophage: In silico 2D-SDS- PAGEAcanthamoeba species and Mycobacterium ulceransAcinetobacter phagesPseudomonas syringae pv. aesculi attacks horse chestnut Aesculus hippocastanum causing Bleeding Canker of Horse ChestnutJournal dedicated to all aspects of Bacteriophage ResearchMolecular TypingPhage titer. One Step Growth CurveKEGG Mycobacterium ulceransL5 mycobacterium phage repressorPHIRE softwareMycobacteriophage DataBaseHow does a person get infected with Mycobacterium marinum?concentration and timing influencePhage isolationPhenotypical Delay in detailMy Point of ViewExclusion Temperate PhagesNew scientific works about Phage TherapyMycobacterium phage D29Japan and new antibioticsM.ulcerans and M.smegmatisWhich is the Phage receptor? Second part.6-10 AugustBurnsBioVet-PA and BioPhage-PA from Biocontrol LimitedAcinetobacter baumannii "In Silico" Agarose Gel ElectrophoresisPhage HuntersformulationDNA SequencingWhich is the Phage receptor? First part.Bxz2 and TM4 mycobacterium phages againWhy this Blog?Phage Therapy in patients with chronic bacterial prostatitisCrystal Structure Of Lysin B From Mycobacteriophage D29With a special focalization on Mycobacterium ulcerans (Buruli ulcer) and ESKAPE bacteria.http://phagetherapylightandshade.blogspot.com/noreply@blogger.com (Rodolfo Berretti)Blogger239125tag:blogger.com,1999:blog-5088549013288027552.post-3964464720168864209Wed, 15 Feb 2012 09:48:00 +00002012-02-15T16:19:23.975+01:00Indian TB cases 'can't be cured' ( But DS6A phage could be used) Web site Web site    DS6A phage (my old idea) From this scientific work : " In 1981 Sula et al. reported positive indicatorswith a reduction in the observed lesions in the spleen, lungs and livers of guinea pigs following therapy with DS-6A. More recent work demonstrated that phage therapy could have a beneficial effect in guinea pigs with disseminated tuberculosis, but http://feedproxy.google.com/~r/PhageTherapyLightAndShade/~3/UOa9vJenxw0/indian-tb-cases-cant-be-cured.htmlnoreply@blogger.com (Rodolfo Berretti)http://phagetherapylightandshade.blogspot.com/2012/02/indian-tb-cases-cant-be-cured.htmltag:blogger.com,1999:blog-5088549013288027552.post-553719170222323010Sat, 28 Jan 2012 20:38:00 +00002012-01-28T21:40:38.111+01:00Phage therapy: myth or reality? WEB SITE http://feedproxy.google.com/~r/PhageTherapyLightAndShade/~3/MMi6RJmDD8c/phage-therapy-myth-or-reality.htmlnoreply@blogger.com (Rodolfo Berretti)http://phagetherapylightandshade.blogspot.com/2012/01/phage-therapy-myth-or-reality.htmltag:blogger.com,1999:blog-5088549013288027552.post-7364919431027532371Sat, 28 Jan 2012 20:17:00 +00002012-01-28T21:29:07.378+01:00PHAGESPOIRS and P.H.A.G.EFrom: PHERECYDES Pharma PHERECYDES Pharma  PHAGESPOIRS P.H.A.G.E http://feedproxy.google.com/~r/PhageTherapyLightAndShade/~3/mRFMb4cOhA4/from-pherecydes-pharmaphagespoirs-and.htmlnoreply@blogger.com (Rodolfo Berretti)http://phagetherapylightandshade.blogspot.com/2012/01/from-pherecydes-pharmaphagespoirs-and.htmltag:blogger.com,1999:blog-5088549013288027552.post-3277554860691598182Sun, 22 Jan 2012 11:18:00 +00002012-01-22T12:26:14.535+01:00ISTC Databases From this web site If you write " Bacteriophage Therapy" in the small window you found a lot of scientific projects about Phage therapy. http://feedproxy.google.com/~r/PhageTherapyLightAndShade/~3/_YOoVuHO5YU/blog-post.htmlnoreply@blogger.com (Rodolfo Berretti)http://phagetherapylightandshade.blogspot.com/2012/01/blog-post.htmltag:blogger.com,1999:blog-5088549013288027552.post-8606384194348341482Sun, 22 Jan 2012 10:46:00 +00002012-01-22T12:26:48.370+01:00CanadaToronto2011ISTCInnovative Drug Discovery Workshop6-10 August From this document  http://feedproxy.google.com/~r/PhageTherapyLightAndShade/~3/29r8BQ1WtaI/nina-chanishviliinnovative-drug.htmlnoreply@blogger.com (Rodolfo Berretti)http://phagetherapylightandshade.blogspot.com/2012/01/nina-chanishviliinnovative-drug.htmltag:blogger.com,1999:blog-5088549013288027552.post-2889588424982371532Fri, 30 Dec 2011 18:46:00 +00002012-01-22T12:27:54.170+01:00New scientific works about Phage Therapy PDF PDF From IDSA http://feedproxy.google.com/~r/PhageTherapyLightAndShade/~3/S2Zgdi2QnKI/blog-post.htmlnoreply@blogger.com (Rodolfo Berretti)http://phagetherapylightandshade.blogspot.com/2011/12/blog-post.htmltag:blogger.com,1999:blog-5088549013288027552.post-3721609876929213695Sun, 06 Nov 2011 08:13:00 +00002011-11-06T10:25:19.680+01:00biotechnology and medicine.2012:Exploiting bacteriophages for bioscience Web site I have selected this:   http://www.ampliphibio.com http://feedproxy.google.com/~r/PhageTherapyLightAndShade/~3/aP9EQwAmWwk/exploiting-bacteriophages-for.htmlnoreply@blogger.com (Rodolfo Berretti)http://phagetherapylightandshade.blogspot.com/2011/11/exploiting-bacteriophages-for.htmltag:blogger.com,1999:blog-5088549013288027552.post-4958666855889375243Sat, 15 Oct 2011 17:57:00 +00002011-10-15T21:13:31.862+02:00Mycobacterium phages for Mycobacterium ulcerans Mycobacterium phage TM4, complete genome Genome Info:Features:BLAST homologs:Links:Review Info: Refseq: NC_003387 Genes: 89COGGenome ProjectPublications: [1] http://feedproxy.google.com/~r/PhageTherapyLightAndShade/~3/A9q_8H31G9s/mycobacterium-phage-tm4-complete-genome.htmlnoreply@blogger.com (Rodolfo Berretti)http://phagetherapylightandshade.blogspot.com/2011/10/mycobacterium-phage-tm4-complete-genome.htmltag:blogger.com,1999:blog-5088549013288027552.post-6426667824411938332Fri, 14 Oct 2011 15:19:00 +00002011-10-15T21:16:28.790+02:00complete genomeMycobacterium ulcerans Agy99 Mycobacterium ulcerans Agy99, complete genome Chromosomes: genome Plasmids: pMUM001 Genome Info:Features:BLAST homologs:Links:Review Info: Refseq: NC_008611 Genes: 4981COGGenome ProjectPublications: [1] http://feedproxy.google.com/~r/PhageTherapyLightAndShade/~3/WWBajppvBTQ/mycobacterium-ulcerans-agy99-complete.htmlnoreply@blogger.com (Rodolfo Berretti)http://phagetherapylightandshade.blogspot.com/2011/10/mycobacterium-ulcerans-agy99-complete.htmltag:blogger.com,1999:blog-5088549013288027552.post-4117236664891971382Fri, 14 Oct 2011 14:43:00 +00002011-11-06T10:29:16.552+01:00Antimicrobial Research ( SAR-2011) Web site http://feedproxy.google.com/~r/PhageTherapyLightAndShade/~3/B9WKWE5bKeY/add-caption.htmlnoreply@blogger.com (Rodolfo Berretti)http://phagetherapylightandshade.blogspot.com/2011/10/add-caption.htmltag:blogger.com,1999:blog-5088549013288027552.post-7865758354745515253Sun, 04 Sep 2011 14:46:00 +00002011-10-02T22:51:54.635+02:00Phage therapy conditions Phage therapy must be used in those conditions  where the therapeutic success is elevated a priori. Why? a-Because Phage Therapy must maintain its best advantage :   the RAPIDITY "GO, KILL and  DISAPPEAR". b- Because Phages must be Lytic and not modified by genetic engineering. c-Because when we use the natural lytic phages in this SHORT TIME  IS IMPOSSIBLE to have:  - a bacterial http://feedproxy.google.com/~r/PhageTherapyLightAndShade/~3/eFWkfrxO4Ts/phage-therapy-must-be-applaied-in-those.htmlnoreply@blogger.com (Rodolfo Berretti)http://phagetherapylightandshade.blogspot.com/2011/09/phage-therapy-must-be-applaied-in-those.htmltag:blogger.com,1999:blog-5088549013288027552.post-7268953870797914281Sun, 21 Aug 2011 18:37:00 +00002011-08-21T20:40:08.778+02:00Clinical Trials for phage therapyClinical Trials for phage therapyhttp://feedproxy.google.com/~r/PhageTherapyLightAndShade/~3/J4xJzWuRaes/clinical-trials-for-phage-therapy.htmlnoreply@blogger.com (Rodolfo Berretti)http://phagetherapylightandshade.blogspot.com/2011/08/clinical-trials-for-phage-therapy.htmltag:blogger.com,1999:blog-5088549013288027552.post-7179537358076252107Sun, 21 Aug 2011 12:14:00 +00002011-08-21T14:42:06.151+02:00Sampling techniques for laboratory diagnosis of Buruli ulcer From: Presentation PDF document Buruli and the best stage for the therapy http://feedproxy.google.com/~r/PhageTherapyLightAndShade/~3/mzkEArB9yVQ/presentation-pdf-document.htmlnoreply@blogger.com (Rodolfo Berretti)http://phagetherapylightandshade.blogspot.com/2011/08/presentation-pdf-document.htmltag:blogger.com,1999:blog-5088549013288027552.post-6385960141843650785Thu, 11 Aug 2011 08:34:00 +00002011-08-11T10:36:15.621+02:00Salmonella: The New SuperbugFrom Medscape http://feedproxy.google.com/~r/PhageTherapyLightAndShade/~3/q6W9QDDjGUI/salmonella-new-superbug.htmlnoreply@blogger.com (Rodolfo Berretti)http://phagetherapylightandshade.blogspot.com/2011/08/salmonella-new-superbug.htmltag:blogger.com,1999:blog-5088549013288027552.post-7749050108132924038Thu, 04 Aug 2011 14:10:00 +00002011-08-04T16:17:56.652+02:00formulationconcentration and timing influencehttp://feedproxy.google.com/~r/PhageTherapyLightAndShade/~3/Zf11nSrVr1M/recent-advances-in-bacteriophage.htmlnoreply@blogger.com (Rodolfo Berretti)http://phagetherapylightandshade.blogspot.com/2011/08/recent-advances-in-bacteriophage.htmltag:blogger.com,1999:blog-5088549013288027552.post-5759567430136980993Mon, 04 Jul 2011 09:42:00 +00002011-07-04T11:45:25.588+02:00Food and BacteriophagesWeb siteGeneral Brochurehttp://feedproxy.google.com/~r/PhageTherapyLightAndShade/~3/euoTYP1kymQ/food-and-bacteriophages.htmlnoreply@blogger.com (Rodolfo Berretti)http://phagetherapylightandshade.blogspot.com/2011/07/food-and-bacteriophages.htmltag:blogger.com,1999:blog-5088549013288027552.post-7859320417314857147Mon, 04 Jul 2011 08:21:00 +00002011-07-04T10:35:53.777+02:00Cronobacter spp.Cronobacterex Enterobacter sakazakiihttp://feedproxy.google.com/~r/PhageTherapyLightAndShade/~3/radIOignSyM/cronobacter.htmlnoreply@blogger.com (Rodolfo Berretti)http://phagetherapylightandshade.blogspot.com/2011/07/cronobacter.htmltag:blogger.com,1999:blog-5088549013288027552.post-8278835679269559306Fri, 24 Jun 2011 08:33:00 +00002011-06-24T10:51:41.130+02:00Morphology of Mature Mycobacterium ulcerans ColoniesFrom A.S.MFig. 1Three-month-old Mycobacterium ulcerans colonies growing on Middlebrook 7H10 agar supplemented with 10% oleic acid, albumin, dextrose, and catalase (OADC). Scale bar = 1 mm.Fig. 2Five-month-old Mycobacterium ulcerans colonies growing on Middlebrook 7H10 agar supplemented with 10% OADC. Scale bar = 1 mm.Macroscopic examination reveals the presence of large and small Mycobacterium http://feedproxy.google.com/~r/PhageTherapyLightAndShade/~3/6hMC3SP3JAY/morphology-of-mature-mycobacterium.htmlnoreply@blogger.com (Rodolfo Berretti)http://phagetherapylightandshade.blogspot.com/2011/06/morphology-of-mature-mycobacterium.htmltag:blogger.com,1999:blog-5088549013288027552.post-834924012457287499Sat, 18 Jun 2011 14:46:00 +00002011-06-19T15:04:45.318+02:00ASM 2011 Annual Scientific Meeting: Microbiology on the EdgeWeb sitehttp://feedproxy.google.com/~r/PhageTherapyLightAndShade/~3/hWD-AbgyTBk/blog-post.htmlnoreply@blogger.com (Rodolfo Berretti)http://phagetherapylightandshade.blogspot.com/2011/06/blog-post.htmltag:blogger.com,1999:blog-5088549013288027552.post-2348625178212474929Sat, 04 Jun 2011 12:20:00 +00002011-06-04T14:45:54.182+02:00MycoBrowserMycoBrowser: a Mycobacterial BrowserClick on the images below to access the manually annotated data set for each organism M. tuberculosis H37Rv M. leprae TN M. marinum M M. smegmatis MC2 <!--a> <ag">rt-tag">tag">s="start-tag">a href="org.pl.cgi?org=mmar6&line=1">[ 1- 3000]<!--a> <a href="org.pl.cgi?org=http://feedproxy.google.com/~r/PhageTherapyLightAndShade/~3/vFXgpqQTths/mycobrowser-mycobacterial-browser-click.htmlnoreply@blogger.com (Rodolfo Berretti)http://phagetherapylightandshade.blogspot.com/2011/06/mycobrowser-mycobacterial-browser-click.htmltag:blogger.com,1999:blog-5088549013288027552.post-39326797263541025Wed, 01 Jun 2011 12:51:00 +00002011-06-04T18:53:01.356+02:00ORFs of MycobacteriophagesORFs of Mycobacteriophage Bxz2 (bpbx2) 1 2 3 4 56 10 11 12 1314 15 16 17 1819 19.1 20 21 223 24http://feedproxy.google.com/~r/PhageTherapyLightAndShade/~3/8pP0wU7ouAU/orfs-of-mycobacteriophage-d29-bpd20-1-2.htmlnoreply@blogger.com (Rodolfo Berretti)http://phagetherapylightandshade.blogspot.com/2011/06/orfs-of-mycobacteriophage-d29-bpd20-1-2.htmltag:blogger.com,1999:blog-5088549013288027552.post-4501001639635624061Tue, 31 May 2011 14:20:00 +00002011-05-31T16:25:49.689+02:00Acanthamoeba species and Mycobacterium ulcerans From this scientific workhttp://feedproxy.google.com/~r/PhageTherapyLightAndShade/~3/UG31HgbP58k/from-this-scientific-work.htmlnoreply@blogger.com (Rodolfo Berretti)http://phagetherapylightandshade.blogspot.com/2011/05/from-this-scientific-work.htmltag:blogger.com,1999:blog-5088549013288027552.post-7577994482515483898Tue, 31 May 2011 06:27:00 +00002011-05-31T08:38:37.295+02:00Phage treatment of human infectionsFrom this ReviewPhage treatment of human infectionsPhage use as probiotics.http://feedproxy.google.com/~r/PhageTherapyLightAndShade/~3/-61TpODVLaM/phage-treatment-of-human-infections.htmlnoreply@blogger.com (Rodolfo Berretti)http://phagetherapylightandshade.blogspot.com/2011/05/phage-treatment-of-human-infections.htmltag:blogger.com,1999:blog-5088549013288027552.post-4836905352467252064Fri, 20 May 2011 17:30:00 +00002011-05-20T19:38:27.172+02:00NewsPODCASTPARLIAMENTARY QUESTIONShttp://feedproxy.google.com/~r/PhageTherapyLightAndShade/~3/kTEHcmUFbBM/questions.htmlnoreply@blogger.com (Rodolfo Berretti)http://phagetherapylightandshade.blogspot.com/2011/05/questions.htmltag:blogger.com,1999:blog-5088549013288027552.post-6230545294927700755Mon, 09 May 2011 19:27:00 +00002011-06-29T09:39:32.161+02:00Buruli and the best stage for the therapyThe clinical feature of the pre-ulcerative stage of the disease are painless nodules, usually occurring singly on the legs or forearms and in theory they are the best target for all therapies. Nodule The lesion starts as a small subcutaneous swelling which is barely palpable but not visible. It gradually increases in size until the skin is slightly raised. The nodule is firm with a regular http://feedproxy.google.com/~r/PhageTherapyLightAndShade/~3/79vrQ6Siuvs/buruli-and-best-target-for-all.htmlnoreply@blogger.com (Rodolfo Berretti)http://phagetherapylightandshade.blogspot.com/2011/05/buruli-and-best-target-for-all.html